Citius Pharma Overview
- Founded
- 2007

- Status
- Public
- Employees
- 10

- Stock Symbol
- CTXR

- Investments
- 2
- Share Price
- $1.26
- (As of Tuesday Closing)
Citius Pharma General Information
Description
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok product and a Hydrocortisone-Lidocaine formulation. Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections. The company's Hydrocortisone-Lidocaine provides anti-inflammatory and anesthetic relief to patients suffering from Grade I and II hemorrhoids. It is primarily operating within the critical care and cancer care market segments.
Contact Information
- 11 Commerce Drive
- First Floor
- Cranford, NJ 07016
- United States
Citius Pharma Timeline
Citius Pharma Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.26 | $1.22 | $0.41 - $1.97 | $67.8M | 55.6M | 802K | -$0.45 |
Citius Pharma Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 | FY 2018 30-Sep-2018 |
---|---|---|---|---|
EV | 50,567 | 50,567 | 17,506 | 25,111 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (17,448) | (17,448) | (15,597) | (12,519) |
Net Income | (17,548) | (17,548) | (15,562) | (12,537) |
Total Assets | 43,774 | 43,774 | 36,746 | 31,051 |
Total Debt | 1,352 | 1,352 | 173 | 173 |
Citius Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Citius Pharma‘s full profile, request access.
Request a free trialCitius Pharma Comparisons
Industry
00000000
000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCitius Pharma Competitors (43)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Boehringer Ingelheim | Corporation | Ingelheim am Rhein, Germany | 00000 | |||
000000 | Corporation | San Francisco, CA | 0 | 0000 | 000000000000 | 0000 |
000 000000 | Private Equity-Backed | Farmville, NC | 000.00 | 000000000 | 000.00 | |
0000000 | Formerly VC-backed | Fremont, CA | 00 | 00000 | 000000000 | 00000 |
00000 000000 | Corporation | Malvern, PA | 000 | 00000 | 000000 - 000 | 00000 |
Citius Pharma Executive Team (9)
Citius Pharma Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Carol Webb | Citius Pharma | Board Member | 000 0000 |
Eugene Holuka MD | Citius Pharma | Board Member | 000 0000 |
Howard Safir | Citius Pharma | Board Member | 000 0000 |
Leonard Mazur | Self | Chairman & Board Member | 000 0000 |
Myron Holubiak | Citius Pharma | Chief Executive Officer & Board Member | 000 0000 |
Citius Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCitius Pharma Acquisitions (2)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000-00000 0000 | 04-Apr-2016 | 000000000000000000 | Biotechnology | 0000000 00000 | |
Trail One | 12-Sep-2014 | Merger/Acquisition | 00.000 | Other Consumer Products and Services |